Factors associated with the frequency of antihypertensive drug adjustments in chronic kidney disease patients: a multicentre, 2-year retrospective study

by Bavanandan, S., Islahudin, F., Lee, F.Y, Makmor-Bakry, M., Wong, H.-S
Published 2021

Kinetics of platelet adhesion to a fibrinogen-coated surface in whole blood under flow conditions

by Avtaeva, Y.N, Caprnda, M., Gabbasov, Z.A, Kruzliak, P., Melnikov, I.S, Mozos, I., Okhota, S.D, Prosecky, R., Rodrigo, L., Zozulya, N.I
Published 2021

Development of measurable criteria to identify and prioritize patients for inclusion in comprehensive medication management programs within primary care settings

by Bishop, M.A, Chang, H.-Y, Kharrazi, H., Kitchen, C., Shermock, K.M, Weiner, J.P
Published 2021

An initial analysis of the UK Medical Cannabis Registry: Outcomes analysis of first 129 patients

by Beri, S., Coomber, R., Erridge, S., Hoare, J., Holvey, C., Kawka, M., Khan, S., Platt, M., Rucker, J.J, Sajad, M., Salazar, O., Sodergren, M.H, Usmani, A., Weatherall, M.W
Published 2021

GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillation

by Bassand, J.-P, Camm, A.J, Dalgaard, F., Fitzmaurice, D.A, Fox, K.A.A, Goldhaber, S.Z, Goto, S., Haas, S., Kakkar, A.K, Kayani, G., Misselwitz, F., Oto, A., Piccini, J.P, Pieper, K.S, Turpie, A.G.G, Verheugt, F.W.A, Virdone, S.
Published 2022

Key use cases for artificial intelligence to reduce the frequency of adverse drug events: a scoping review

by Amato, M.G, Bain, P.A, Bates, D.W, Co, Z., Dulgarian, S., Edrees, H., Foer, D., Kuznetsova, M., Purcell Jackson, G., Rhee, K., Seger, D.L, Simona, A., Song, W., Syrowatka, A.
Published 2022

DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases

by Anderson, J.E, Bakris, G.L, Ballantyne, C.M, Beckman, J.A, Bhatt, D.L, Bloomgarden, Z.T, Bozkurt, B., Budoff, M.J, Butler, J., Dagogo-Jack, S., de Boer, I.H, DeFronzo, R.A, Eckel, R.H, Einhorn, D., Fonseca, V.A, Green, J.B, Grunberger, G., Guerin, C., Handelsman, Y., Inzucchi, S.E, Jellinger, P.S, Kosiborod, M.N, Kushner, P., Lepor, N., Mende, C.W, Michos, E.D, Plutzky, J., Taub, P.R, Umpierrez, G.E, Vaduganathan, M., Weir, M.R
Published 2022

White matter hyperintensities induce distal deficits in the connected fibers

by Cheng, X., Ding, D., Dong, Q., Gao, J.-H, He, J., Liang, X., Liang, Z., Liu, Y., Nguchu, B.A, Qiu, B., Wang, X., Wang, Y., Wang, Y., Wang, Y., Wu, J., Xia, Y., Yang, L., Ying, Y., Zhang, D., Zhao, Q.
Published 2021

Tolerability and Feasibility of X-ray Guided Non-Invasive Ablation of the Medial Branch Nerve with Focused Ultrasound: Preliminary Proof of Concept in a Pre-clinical Model

by Aginsky, R., Aubry, J.-F, Chen, J., Gofeld, M., Hananel, A., LeBlang, S., Perez, J., Shir, Y.
Published 2021

Population pharmacokinetic–pharmacodynamic modeling of PB2452, a monoclonal antibody fragment being developed as a ticagrelor reversal agent, in healthy volunteers

by Arnold, S.E, Bhatt, D.L, Kathman, S.J, Lee, J.S, Wheeler, J.J
Published 2022

Polypill with or without aspirin in persons without cardiovascular disease

by Bosch, J., Christou, C., Dagenais, G., Dans, A., Gamra, H., Gao, P., Girish, P., Joseph, P., Lopez-Jaramillo, P., McCready, T., Pais, P., Rocha, C., Santoso, A., Talukder, S., Teo, K., Tyrwhitt, J., Xavier, D., Xavier, F., Yeates, K., Yusoff, K., Yusuf, S.
Published 2021

Cardiovascular risk and events in 17 low-, middle-, and high-income countries

by Anand, S., Avezum, A., Bo, J., Chifamba, J., Dagenais, G., Diaz, R., Gupta, R., Iqbal, R., Islam, S., Ismail, N., Kelishadi, R., Kruger, A., Kumar, R., Lanas, F., Lear, S., Li, W., Liu, L., Liu, T., Lopez-Jaramillo, P., Lou, Q., Lu, F., McKee, M., McQueen, M., Mohan, V., Mony, P., Oguz, A., Puoane, T., Rahman, O., Rangarajan, S., Rosengren, A., Swaminathan, S., Szuba, A., Teo, K., Vijayakumar, K., Wielgosz, A., Yu, L., Yusoff, K., Yusuf, S., Yusufali, A., Zhang, S.
Published 2014

Ticagrelor induces paraoxonase-1 (PON1) and better protects hypercholesterolemic mice against atherosclerosis compared to clopidogrel

by Chunhacha, P., Fujise, K., Halim, H., Pinkaew, D., Sinthujaroen, P., Thiagarajan, P.
Published 2018

Inequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study

by AlHabib, K.F, Avezum, A., Bai, X., Chifamba, J., Chow, C.K, Corsi, D.J, Dagenais, G.R, Dans, A.L, Diaz, R., Erbakan, A.N, Iqbal, R., Ismail, N., Kelishadi, R., Khatib, R., Lanas, F., Lear, S.A, Li, W., Liu, J., Lopez-Jaramillo, P., McKee, M., Mohan, V., Monsef, N., Mony, P.K, Murphy, A., O'Donnell, O., Palafox, B., Perel, P., Puoane, T., Rangarajan, S., Rosengren, A., Schutte, A.E, Sintaha, M., Stuckler, D., Teo, K.K, Wielgosz, A., Yeates, K., Yin, L., Yusoff, K., Yusuf, S., Zatońska, K.
Published 2018

Secondary prevention patterns in persons with pre-existing coronary artery disease: Are we getting it right?

by Abdul Hafidz, M.I, Hadi, M.F, Lee, Z.-V, Mahmood Zuhdi, A.S, Zainudin, L.D
Published 2018

Impact of the Additive Effect of Angiotensin-Converting Enzyme Inhibitors and/or Statins with Antiplatelet Medication on Mortality After Acute Ischaemic Stroke

by Al-Jabi, S.W, Aziz, N.A, Hassan, Y., Looi, I., Zyoud, S.H

Zingiber zerumbet (L.) Smith: A review of its ethnomedicinal, chemical, and pharmacological uses

by Affandi, M.M.R.M.M, Jofrry, S.M, Salleh, M.Z, Teh, L.K, Yob, N.J, Zakaria, Z.A

Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin

by Alings, M., Anand, S.S, Avezum, A., Bhatt, D.L, Bosch, J., Branch, K.R.H, Bruns, N.C, Commerford, P.J, COMPASS Investigators, Connolly, S.J, Dagenais, G.R, Dans, A.L, Diaz, R., Dyal, L., Eikelboom, J.W, Ertl, G., Felix, C., Fox, K.A.A, Guzik, T.J, Hart, R.G, Hori, M., Kakkar, A.K, Keltai, M., Kim, J.-H, Lanas, F., Leong, D., Lewis, B.S, Liang, Y., Lonn, E.M, Lopez-Jaramillo, P., Maggioni, A.P, Metsarinne, K.P, Moayyedi, P., Muehlhofer, E., O'Donnell, M., Parkhomenko, A.N, Piegas, L.S, Pogosova, N., Probstfield, J., Ryden, L., Shestakovska, O., Steg, P.G, Störk, S., Tonkin, A.M, Torp-Pedersen, C., Verhamme, P.B, Vinereanu, D., Widimsky, P., Yusoff, K., Yusuf, S., Zhu, J.
Published 2019

Inappropriate prescribing defined by STOPP and START criteria and its association with adverse drug events among hospitalized older patients: A multicentre, prospective study

by Aziz, N.A, Azmy, M.T, Fahrni, M.L, Hassan, Y., Usir, E.
Published 2019

Efficacy of aspirin, clopidogrel, and ticlopidine in stroke prevention: A population-based case-cohort study in Taiwan

by Hsu, Y.-H, Ong, C.-T, Tsai, C.-F, Wong, Y.-S
Published 2021